HIGHLIGHTS
- who: korisnik from the (UNIVERSITY) have published the research work: Strana 538 VOJNOSANITETSKI PREGLED Volumen 64, Broj 8 Correspondence to: Svetlana Pavlović, Klinički centar Niš, Klinika za urologiju, 18 000 Niš, Srbija. E-mail: drsvetlana2004, in the Journal: (JOURNAL)
- what: The aim of this study was to determine the level of inhibition of FXa by the use of prophylactic doses of LMH nadroparin-calcium and reviparine-sodium which were applied in urological patients with moderate risk for VTE and PE.
SUMMARY
Heparin, low-molecular-weight; nadroparin; drug therapy; dose-response . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.